ICTTX
Price
$15.86
Change
+$0.01 (+0.06%)
Updated
Sep 17 closing price
Net Assets
79.52M
PRGTX
Price
$25.10
Change
-$0.18 (-0.71%)
Updated
Sep 17 closing price
Net Assets
5.49B
Interact to see
Advertisement

ICTTX vs PRGTX

Header iconICTTX vs PRGTX Comparison
Open Charts ICTTX vs PRGTXBanner chart's image
ICON Health and Information Tech I
Price$15.86
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets79.52M
T. Rowe Price Global Technology
Price$25.10
Change-$0.18 (-0.71%)
VolumeN/A
Net Assets5.49B
ICTTX vs PRGTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ICTTX vs. PRGTX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICTTX is a Buy and PRGTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 5.49B vs. ICTTX (79.5M). ICTTX (0.00) and PRGTX (0.00) have matching dividends . ICTTX was incepted earlier than PRGTX: ICTTX (15 years) vs PRGTX (25 years). ICTTX (1.54) is less costly to investors than PRGTX (0.92). PRGTX is a more actively managed with annual turnover of: 31.40 vs. ICTTX (17.00). ICTTX has a lower initial minimum investment than PRGTX: ICTTX (1000) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 32.01 vs. ICTTX (5.67). PRGTX return over 5 years is better than : 11.41 vs. ICTTX (-9.17).
ICTTXPRGTXICTTX / PRGTX
Total Expense Ratio1.540.92167%
Annual Report Gross Expense Ratio1.540.92167%
Fund Existence15 years25 years-
Gain YTD11.22821.18953%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets79.5M5.49B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.6732.0118%
Returns for 3 years-1.18108.07-1%
Returns for 5 years-9.1711.41-80%
Returns for 10 years6.9788.248%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSGAX30.82N/A
N/A
JHancock U.S. Growth A
BPLSX14.80N/A
N/A
Boston Partners Long/Short Equity Instl
PAMCX96.18N/A
N/A
T. Rowe Price Mid-Cap Growth Adv
MVTRX11.67N/A
N/A
Transamerica Mid Cap Value Opps R6
FIKLX10.54N/A
N/A
Fidelity Advisor Intl Real Estate Z